期刊
ACS APPLIED MATERIALS & INTERFACES
卷 8, 期 19, 页码 11969-11979出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsami.6b01135
关键词
vaccine; adjuvant; immune response; hyaluronic acid; cationic lipid-PLGA hybrid nanoparticles
资金
- Natural Science Foundation of China [50903093, 31200674, 51373199]
- Tianjin Natural Science Foundation [15JCYBJC18400, 15JCYBJC47600]
Here, we investigated the use of hyaluronic acid (HA)-decorated cationic lipid-poly(lactide-co-glycolide) acid (PLGA) hybrid nanoparticles (HA-DOTAP-PLGA NPs) as vaccine delivery vehicles, which were originally developed for the cytosolic delivery of genes. Our results demonstrated that after the NPs uptake by dendritic cells (DCs), some of the antigens that were encapsulated in HA-DOTAP-PLGA NPs escaped to the cytosolic compartment, and whereas some of the antigens remained in the endosbmal/lysosomal compartment, where both MHC-I and MHC-II antigen presentation occurred. Moreover, HA-DOTAP-PLGA NPs led to the up-regulation of MHC, costimulatory molecules, and cytokines. In vivo experiments further revealed that more powerful immune responses were induced from mite immunized with HA-DOTAP-PLGA NPs when compared with cationic lipid-PLGA nanoparticles and-free ovalbumin (OVA); the responses included antigen-specific CD4(+) and CD8(+) T-cell responses, the production of antigen-specific IgG antibodies and the generation of memory CD4(+). and CD8(+) T cells. Overall, these data demonstrate the high potential of HA-DOTAP-PLGA NPs for use as vaccine delivery vehicles to elevate cellular and humoral immune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据